Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid

Colloids and Surfaces B: Biointerfaces

Volumn 112, Issue , 2013, Pages 87-95

  Bitan Cherbakovsky, Liron ^a   Aserin, Abraham ^a   Garti, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cubic mesophases; Drug release; Hexagonal mesophases; Lamellar mesophases; Vitamin E

Indexed keywords

CUBIC MESOPHASES; DRUG RELEASE; HEXAGONAL MESOPHASES; LAMELLAR MESOPHASES; VITAMIN-E;

DENDRIMERS; NEMATIC LIQUID CRYSTALS; SOLUBILITY;

LAMELLAR STRUCTURES;

ALPHA TOCOPHEROL; DENDRIMER; GALLIC ACID; GLYCEROL OLEATE; POLYPROPYLENEIMINE; TRIOCTANOIN; UNCLASSIFIED DRUG; WATER;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFUSION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; LIQUID CRYSTAL; PRIORITY JOURNAL; STRUCTURE ANALYSIS; ULTRAVIOLET SPECTROPHOTOMETRY; WATER CONTENT; X RAY CRYSTALLOGRAPHY;

CUBIC MESOPHASES; DRUG RELEASE; HEXAGONAL MESOPHASES; LAMELLAR MESOPHASES; VITAMIN E;

DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GALLIC ACID; GLYCERIDES; LIQUID CRYSTALS; MOLECULAR STRUCTURE; NANOSTRUCTURES; POLYPROPYLENES; SCATTERING, SMALL ANGLE; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY; WATER; X-RAY DIFFRACTION;

EID: 84882983685     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.06.051     Document Type: Article

References (56)

1. Sharma A., Gautam S.P., Gupta A.K. Surface modified dendrimers: synthesis and characterization for cancer targeted drug delivery. Bioorg. Med. Chem. 2011, 19:3341.
2. Patri A.K., Kukowska-Latallo J.F., Baker J.R. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug Deliv. Rev. 2005, 57:2203.
3. Khan M.K., Nigavekar S.S., Minc L.D., Kariapper M.S.T., Nair B.M., Lesniak W.G., Balogh L.P. In vivo biodistribution of dendrimers and dendrimer nanocomposites-implications for cancer imaging and therapy. Technol. Cancer Res. Treat. 2005, 4:603.
4. Tomalia D.A., Reyna L.A., Svenson S. Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem. Soc. Trans. 2007, 35:61.
5. Gillies E.R., Frechet J.M.J. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 2005, 10:35.
6. Avila-Salas F., Sandoval C., Caballero J., Guinez-Molinos S., Santos L.S., Cachau R.E., Gonzalez-Nilo F.D. Study of interaction energies between the PAMAM dendrimer and nonsteroidal anti-inflammatory drug using a distributed computational strategy and experimental analysis by ESI-MS/MS. J. Phys. Chem. B 2012, 116:2031.
7. Maingi V., Kumar M.V.S., Maiti P.K. PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern. J. Phys. Chem. B 2012, 116:4370.
8. Shao N., Gong X., Chen Q., Cheng Y. Fast screening of dendrimer-binding compounds by diffusion NMR techniques. J. Phys. Chem. B 2012, 116:5398.
9. Ionov M., Ciepluch K., Klajnert B., Glinska S., Gomez-Ramirez R., Javier de la Mata F., Angeles Munoz-Fernandez M., Bryszewska M. Complexation of HIV derived peptides with carbosilane dendrimers. Colloids Surf. B 2013, 101:236-242.
10. Patri A.K., Majoros I.J., Baker J.R. Dendritic polymer macromolecular carriers for drug delivery. Curr. Opin. Chem. Biol. 2002, 6:466.
11. Rokach S., Ottaviani M.F., Shames A.I., Nir I., Aserin A., Garti N. W/O microemulsions as dendrimer nanocarriers: an EPR study. J. Phys. Chem. B 2012, 116:12633.
12. Zhao L., Li C., Zhang J., Wu Q., Xu T., Cheng Y. Interactions between dendrimers and ionic liquids revealed by pulsed field gradient and nuclear Overhauser effect NMR studies. J. Phys. Chem. B 2012, 116:7203.
13. Ciolkowski M., Palecz B., Appelhans D., Voit B., Klajnert B., Bryszewska M. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability. Colloids Surf. B 2012, 95:103-108.
14. Naylor A.M., Goddard W.A., Kiefer G.E., Tomalia D.A. Starburst dendrimers .5. Molecular shape control. J. Am. Chem. Soc. 1989, 111:2339.
15. Newkome G.R., Moorefield C.N., Baker G.R., Saunders M.J., Grossman S.H. Chemistry of micelles. 13. Unimolecular micelles. Angew. Chem. Int. Ed. 1991, 30:1178.
16. Jansen J., Debrabandervandenberg E.M.M., Meijer E.W. Encapsulation of guest molecules into a dendritic box. Science 1994, 266:1226.
17. Jansen J., Meijer E.W., Debrabandervandenberg E.M.M. The dendritic box-shape-selective liberation of encapsulated guests. J. Am. Chem. Soc. 1995, 117:4417.
18. Fang M., Zhang J., Wu Q., Xu T., Cheng Y. Host-guest chemistry of dendrimer-drug complexes: 7. Formation of stable inclusions between acetylated dendrimers and drugs bearing multiple charges. J. Phys. Chem. B 2012, 116:3075.
19. Menjoge A.R., Kannan R.M., Tomalia D.A. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov. Today 2010, 15:171.
20. Cheng Y.Y., Xu Z.H., Ma M.L., Xu T.W. Dendrimers as drug carriers: applications in different routes of drug administration. J. Pharm. Sci. 2008, 97:123.
21. Paleos C.M., Tsiourvas D., Sideratou Z. Molecular engineering of dendritic polymers and their application as drug and gene delivery systems. Mol. Pharmaceut. 2007, 4:169.
22. Kato Y., Seita T., Kuwabara T., Sugiyama Y. Kinetic analysis of receptor-mediated endocytosis (RME) of proteins and peptides: use of RME as a drug delivery system. J. Controlled Release 1996, 39:191.
23. Lespade L., Bercion S. Theoretical study of the mechanism of inhibition of xanthine oxidase by flavonoids and gallic acid derivatives. J. Phys. Chem. B 2010, 114:921.
24. Ohno Y., Fukuda K., Takemura G., Toyota M., Watanabe M., Yasuda N., Qiu X.B., Maruyama R., Akao S., Gotou K., Fujiwara T., Fujiwara H. Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999, 10:845.
25. Inoue M., Sakaguchi N., Isuzugawa K., Tani H., Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol. Pharm. Bull. 2000, 23:1153.
26. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91:123.
27. Serrano A., Palacios C., Roy G., Cespon C., Villar M.L., Nocito M., Gonzalez-Porque P. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch. Biochem. Biophys. 1998, 350:49.
28. Yoshioka K., Kataoka T., Hayashi T., Hasegawa M., Ishi Y., Hibasami H. Induction of apoptosis by gallic acid in human stomach cancer KATO III and colon adenocarcinoma COLO 205 cell lines. Oncol. Rep. 2000, 7:1221.
29. Dalla Pellegrina C., Padovani G., Mainente F., Zoccatelli G., Bissoli G., Mosconi S., Veneri G., Peruffo A., Andrighetto G., Rizzi C., Chignola R. Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis. Cancer Lett. 2005, 226:17.
30. Lo C., Lai T.-Y., Yang J.-H., Yang J.-S., Ma Y.-S., Weng S.-W., Chen Y.-Y., Lin J.-G., Chung J.-G. Gallic acid induces apoptosis in A375.S2 human melanoma cells through caspase-dependent and -independent pathways. Int. J. Oncol. 2010, 37:377.
31. Klajnert B., Bryszewska A. Interactions between PAMAM dendrimers and gallic acid molecules studied by spectrofluorimetric methods. Bioelectrochemistry 2007, 70:50.
32. Bitan-Cherbakovsky L., Libster D., Aserin A., Garti N. Complex dendrimer-lyotropic liquid crystalline systems: structural behavior and interactions. J. Phys. Chem. B 2011, 115:11984.
33. Bitan-Cherbakovsky L., Libster D., Ottaviani M.F., Aserin A., Garti N., Structural Behavior Interactions of dendrimer within lyotropic liquid crystals monitored by EPR spectroscopy and rheology. J. Phys. Chem. B 2012, 116:2420.
34. Bitan-Cherbakovsky L., Yuli-Amar I., Aserin A., Garti N. Structural rearrangements and interaction within H-II mesophase induced by cosolubilization of vitamin E and ascorbic acid. Langmuir 2009, 25:13106.
35. Amar-Yuli I., Aserin A., Garti N. Solubilization of nutraceuticals into reverse hexagonal mesophases. J. Phys. Chem. B 2008, 112:10171.
36. Amar-Yuli I., Garti N. Transitions induced by solubilized fat into reverse hexagonal mesophases. Colloids Surf. B 2005, 43:72.
37. Lake J.A. An iterative method of slit-correcting small angle X-ray data. Acta Crystallogr. 1967, 23:191.
38. Nielsen L., Khurana R., Coats A., Frokjaer S., Brange J., Vyas S., Uversky V.N., Fink A.L. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 2001, 40:6036.
39. Amar-Yuli I., Wachtel E., Shalev D.E., Moshe H., Aserin A., Garti N. Thermally induced fluid reversed hexagonal (H-II) mesophase. J. Phys. Chem. B 2007, 111:13544.
40. Hubner W., Mantsch H.H. Orientation of specifically C-13O labeled phosphatidylcholine multilayers from polarized attenuated total reflection FT-IR spectroscopy. Biophys. J. 1991, 59:1261.
41. Razumas V., Larsson K., Miezis Y., Nylander T. A cubic monoolein cytochrome c water phase: X-ray diffraction, FT-IR, differential scanning calorimetric, and electrochemical studies. J. Phys. Chem. 1996, 100:11766.
42. Nilsson A., Holmgren A., Lindblom G. Fourier-transform infrared-spectroscopy study of dioleoleylphosphatidylcholine and monooleoylglycerol in lamellar and cubic liquid-crystals. Biochemistry 1991, 30:2126.
43. Sharp K.A., Madan B., Manas E., Vanderkooi J.M. Water structure changes induced by hydrophobic and polar solutes revealed by simulations and infrared spectroscopy. J. Chem. Phys. 2001, 114:1791.
44. Nilsson A., Holmgren A., Lindblom G. An FTIR study of the hydration and molecular ordering at phase-transitions in the monooleoylglycerol water-system. Chem. Phys. Lipids 1994, 71:119.
45. Larsson K., Fontell K., Krog N. Structural relationships between lamellar, cubic and hexagonal phases in monoglyceride-water systems-possibility of cubic structures in biological systems. Chem. Phys. Lipids 1980, 27:321.
46. Larsson K. Cubic lipid-water phases-structures and biomembrane aspects. J. Phys. Chem. 1989, 93:7304.
47. Qiu H., Caffrey M. The phase diagram of the monoolein/water system: metastability and equilibrium aspects. Biomaterials 2000, 21:223.
48. Misquitta Y., Caffrey M. Rational design of lipid molecular structure: a case study involving the C19:1c10 monoacylglycerol. Biophys. J. 2001, 81:1047.
49. Amar-Yuli I., Adamcik J., Blau S., Aserin A., Garti N., Mezzenga R. Controlled embedment and release of DNA from lipidic reverse columnar hexagonal mesophases. Soft Matter 2011, 7:8162.
50. Mezzenga R., Schurtenberger P., Burbidge A., Michel M. Understanding foods as soft materials. Nat. Mater. 2005, 4:729.
51. Sagalowicz L., Mezzenga R., Leser M.E. Investigating reversed liquid crystalline mesophases. Curr. Opin. Colloid Interface Sci. 2006, 11:224.
52. Fong W.-K., Hanley T., Boyd B.J. Stimuli responsive liquid crystals provide 'on-demand' drug delivery in vitro and in vivo. J. Control. Release 2009, 135:218.
53. Negrini R. Mezzenga, pH-responsive lyotropic liquid crystals for controlled drug delivery. Langmuir 2011, 27:5296.
54. Garti N., Hoshen G., Aserin A. Lipolysis and structure controlled drug release from reversed hexagonal mesophase. Colloids Surf. B 2012, 94:36.
55. Yariv D., Efrat R., Libster D., Aserin A., Garti N. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems. Colloids Surf. B 2010, 78:185.
56. II mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac. Colloids Surf. B 2010, 77:131.